THERAGEN ETEX (066700) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, THERAGEN ETEX (066700) reported revenue of 271.6 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
2025271.6 billion KRW10.2 billion KRW11.7 billion KRW[source]
2024249.6 billion KRW12.5 billion KRW-39.3 billion KRW[source]
2023221.7 billion KRW11.6 billion KRW28.4 billion KRW[source]
2022193.4 billion KRW10.3 billion KRW11.0 billion KRW[source]
2021166.6 billion KRW-7.4 billion KRW-11.4 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
2025181.1 billion KRW58.5 billion KRW122.7 billion KRW[source]
2024161.5 billion KRW64.6 billion KRW96.9 billion KRW[source]
2023243.1 billion KRW49.9 billion KRW114.5 billion KRW[source]
2022187.0 billion KRW44.0 billion KRW143.0 billion KRW[source]
2021291.0 billion KRW70.5 billion KRW220.6 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice